Atlas Trials

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Clinical trial NCT02945579 · RECRUITING

Trial details

NCT number
NCT02945579
Sponsor
M.D. Anderson Cancer Center
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Estrogen Receptor NegativeHER2 Positive Breast CarcinomaHER2/Neu NegativeInvasive Breast CarcinomaProgesterone Receptor NegativeStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7Stage IB Breast Cancer AJCC v7Stage II Breast Cancer AJCC v6 and v7Stage IIA Breast Cancer AJCC v6 and v7Stage IIB Breast Cancer AJCC v6 and v7Triple-Negative Breast Carcinoma
Start date
2017-01-20
Primary completion
2028-01-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.